PUBLISHER: The Business Research Company | PRODUCT CODE: 1409584
PUBLISHER: The Business Research Company | PRODUCT CODE: 1409584
Male Hypogonadism Global Market Report 2024
“Male Hypogonadism Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on male hypogonadism market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for male hypogonadism? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The male hypogonadism market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Scope
Markets Covered:
- 1) By Type: Klinefelters Syndrome; Kallmann Syndrome; Pituitary Disorders; Other Types
- 2) By Drug Delivery: Topical Gels; Injectables; Transdermal Patches; Other Drug Deliveries
- 3) By Therapy: Testosterone Therapy; Gonadotropin-Releasing Hormone Therapy
- Companies Mentioned: Allergan plc; Pfizer Inc.; Bayer AG; Eli Lilly and Company Ltd.; Endo International plc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Executive Summary
Male hypogonadism is a condition characterized by insufficient production of the hormone testosterone in the body. Testosterone plays a crucial role as the primary male sex hormone, and its presence is vital for the development and growth of men during puberty.
The main types of male hypogonadism include Klinefelter syndrome, Kallmann syndrome, pituitary disorders, and others. Klinefelter syndrome is a hereditary disorder that manifests in boys when they have an extra copy of the X chromosome at birth. Treatment for male hypogonadism often involves testosterone therapy delivered through various methods such as topical gels, injectables, transdermal patches, and gonadotropin-releasing hormone therapy.
The male hypogonadism market research report is one of a series of new reports from The Business Research Company that provides male hypogonadism market statistics, including male hypogonadism industry global market size, regional shares, competitors with a male hypogonadism market share, detailed male hypogonadism market segments, market trends, and opportunities, and any further data you may need to thrive in the male hypogonadism industry. This male hypogonadism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The male hypogonadism market size has grown strongly in recent years. It will grow from $3.55 billion in 2023 to $3.8 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth observed during the historic period can be attributed to factors such as an aging population, increased awareness and diagnosis, lifestyle factors, the prevalence of chronic illnesses, and the patterns of treatment-seeking behavior.
The male hypogonadism market size is expected to see strong growth in the next few years. It will grow to $4.77 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The increase projected for the upcoming period can be ascribed to the heightened awareness, the prevalence of lifestyle-related conditions, advancements in therapies, a focus on men's health, and improved accessibility to telemedicine and healthcare. Notable trends expected in the forecast period encompass a heightened emphasis on psychological and sexual health, the exploration of nutraceuticals and lifestyle interventions, the expansion of markets in emerging economies, collaborative research initiatives, and an increased focus on long-term safety and monitoring.
The anticipated rise in infertility rates is poised to drive the expansion of the male hypogonadism market in the future. Infertility, defined as the inability to conceive after 12 months or more of frequent, unprotected sexual activity, affects both male and female reproductive systems. Male hypogonadism, a potential contributor to reduced sperm production and infertility, is expected to witness increased prevalence, further fueling the growth of the male hypogonadism market. Notably, data from the National Institutes of Health (NIH) in North America, as of March 2023, indicates male infertility rates estimated at 4.5% - 6%, 9% in Australia, and possibly ranging from 8% to 12% in Eastern Europe. Additionally, a 2021 study in the Libyan Journal of Medical Sciences attributes around 70% of infertility cases in Libya to male factors, underscoring the role of male hypogonadism in this context.
The escalating incidence of chronic diseases is anticipated to be a driving force behind the male hypogonadism market's growth. Chronic diseases, lasting a year or more and requiring continuous medical attention, significantly impact hormone production pathways, leading to an elevated occurrence of male hypogonadism due to their effects on testosterone synthesis and regulation. For example, projections from the National Center for Biotechnology Information (NCBI) in January 2023 suggest a substantial surge, reaching 142.66 million individuals aged 50 and older with at least one chronic illness by 2050, compared to 71.522 million in 2020. Consequently, the rising prevalence of chronic diseases is expected to contribute to the expansion of the male hypogonadism market.
A prominent trend is the increasing popularity of product innovations. Companies within this sector are actively pursuing the development of novel products to maintain their competitive positions. For example, in June 2022, Halozyme, a biotechnology company based in the United States, introduced Tlando, an oral treatment designed for testosterone replacement therapy in male hypogonadism. Tlando, a prescription drug containing testosterone, represents a milestone as the first FDA-approved oral testosterone treatment. Its application is targeted at adult men experiencing low or no testosterone due to specific medical conditions.
Major players in the male hypogonadism market are strategically directing their efforts toward creating innovative products, including digital-forward platforms. These platforms aim to engage patients through telemedicine, provide educational resources, and simplify access to treatments, thereby revolutionizing the care landscape for male hypogonadism while enhancing patient support and treatment accessibility. An illustrative example is Base Healthcare, a U.S.-based men's virtual health platform, which, in October 2022, launched a subscription-based platform exclusively for men. This digital health platform prioritizes fundamental health and hormone enhancement through oral testosterone treatment, offering users convenient access to adequate testosterone therapy (ATT), certified medical professionals, and personalized health guidance.
In July 2022, Gruenenthal, a pharmaceutical company headquartered in Germany, acquired Nebido from Bayer AG for €500 million ($551.32 million). This acquisition is strategically aimed at enhancing Gruenenthal's profitability and enabling increased investment in research and development to pave the way for the next generation of pain therapies. Bayer AG, a renowned German pharmaceutical company, plays a pivotal role in the male hypogonadism treatment sector, further influencing the market landscape.
Major companies operating in the male hypogonadism market report are Allergan plc, Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, AstraZeneca plc, IBSA Institut Biochimique SA, Juniper Laboratories SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Endocrine Technologies Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Mereo BioPharma Group plc, Myovant Sciences Ltd., Novartis AG, Novo Nordisk A/S, Repros Therapeutics Inc., Sandoz International GmbH, Sanofi SA, Sermonix Pharmaceuticals LLC, Shionogi & Co. Ltd., Solvay SA, TherapeuticsMD Inc., Viking Therapeutics Inc
North America was the largest region in the male hypogonadism market in 2023. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the male hypogonadism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The male hypogonadism market includes revenues earned by entities through hormone testing, semen analysis, pituitary imaging, genetic studies, and testicular biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Table of Contents
1. Executive Summary
2. Male Hypogonadism Market Characteristics
3. Male Hypogonadism Market Trends And Strategies
4. Male Hypogonadism Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On the Market
- 4.2. Ukraine-Russia War Impact On the Market
- 4.3. COVID-19 Impact On the Market
5. Global Male Hypogonadism Market Size and Growth
- 5.1. Global Male Hypogonadism Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Male Hypogonadism Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Male Hypogonadism Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Male Hypogonadism Market Segmentation
- 6.1. Global Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Klinefelters Syndrome
- Kallmann Syndrome
- Pituitary Disorders
- Other Types
- 6.2. Global Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Topical Gels
- Injectables
- Transdermal Patches
- Other Drug Deliveries
- 6.3. Global Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Testosterone Therapy
- Gonadotropin-Releasing Hormone Therapy
7. Male Hypogonadism Market Regional And Country Analysis
- 7.1. Global Male Hypogonadism Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Male Hypogonadism Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Male Hypogonadism Market
- 8.1. Asia-Pacific Male Hypogonadism Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Male Hypogonadism Market
- 9.1. China Male Hypogonadism Market Overview
- 9.2. China Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Male Hypogonadism Market
- 10.1. India Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Male Hypogonadism Market
- 11.1. Japan Male Hypogonadism Market Overview
- 11.2. Japan Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Male Hypogonadism Market
- 12.1. Australia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Male Hypogonadism Market
- 13.1. Indonesia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Male Hypogonadism Market
- 14.1. South Korea Male Hypogonadism Market Overview
- 14.2. South Korea Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Male Hypogonadism Market
- 15.1. Western Europe Male Hypogonadism Market Overview
- 15.2. Western Europe Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Male Hypogonadism Market
- 16.1. UK Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Male Hypogonadism Market
- 17.1. Germany Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Male Hypogonadism Market
- 18.1. France Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Male Hypogonadism Market
- 19.1. Italy Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Male Hypogonadism Market
- 20.1. Spain Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Male Hypogonadism Market
- 21.1. Eastern Europe Male Hypogonadism Market Overview
- 21.2. Eastern Europe Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Male Hypogonadism Market
- 22.1. Russia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Male Hypogonadism Market
- 23.1. North America Male Hypogonadism Market Overview
- 23.2. North America Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Male Hypogonadism Market
- 24.1. USA Male Hypogonadism Market Overview
- 24.2. USA Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Male Hypogonadism Market
- 25.1. Canada Male Hypogonadism Market Overview
- 25.2. Canada Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Male Hypogonadism Market
- 26.1. South America Male Hypogonadism Market Overview
- 26.2. South America Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Male Hypogonadism Market
- 27.1. Brazil Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Male Hypogonadism Market
- 28.1. Middle East Male Hypogonadism Market Overview
- 28.2. Middle East Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Male Hypogonadism Market
- 29.1. Africa Male Hypogonadism Market Overview
- 29.2. Africa Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Male Hypogonadism Market Competitive Landscape And Company Profiles
- 30.1. Male Hypogonadism Market Competitive Landscape
- 30.2. Male Hypogonadism Market Company Profiles
- 30.2.1. Allergan plc
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Bayer AG
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Eli Lilly and Company Ltd.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Endo International plc.
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Allergan plc
31. Global Male Hypogonadism Market Competitive Benchmarking
32. Global Male Hypogonadism Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Male Hypogonadism Market
34. Male Hypogonadism Market Future Outlook and Potential Analysis
- 34.1 Male Hypogonadism Market In 2028 - Countries Offering Most New Opportunities
- 34.2 Male Hypogonadism Market In 2028 - Segments Offering Most New Opportunities
- 34.3 Male Hypogonadism Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies
35. Appendix
- 35.1. Abbreviations
- 35.2. Currencies
- 35.3. Historic And Forecast Inflation Rates
- 35.4. Research Inquiries
- 35.5. The Business Research Company
- 35.6. Copyright And Disclaimer
